CJC-1295 (no DAC) 15mg + Ipamorelin 15mg
$199.00
The CJC-1295 + Ipamorelin Blend brings together two peptides frequently examined for their roles in growth-hormone–related signaling and pathway selectivity. Clean structure. Defined investigative value for controlled laboratory research.
All products are sold strictly for laboratory and research applications. They are not approved for human or animal use. No medical, diagnostic, or therapeutic claims are made or implied.
- Description
- Certificate of Analysis
- Store Policies
- Inquiries
Description
This blend pairs CJC-1295, a synthetic GHRH analog, with Ipamorelin, a selective pentapeptide commonly referenced in receptor-adjacent signaling studies. Together, they provide a structured platform for exploring pathway specificity, comparative analog behavior, and growth-hormone–related signaling in controlled in-vitro environments.
Research Overview
Preclinical literature often examines how CJC-1295 engages GHRH-receptor pathways while Ipamorelin enables targeted exploration of selective receptor activation. Blending the two creates an opportunity to investigate signaling fidelity, sequence-dependent behavior, and pathway mapping without implying any physiological outcomes beyond the research setting.
Key Research Areas Commonly Discussed
- Growth-hormone–related signaling models
- Comparative analysis of GHRH analogs and selective pentapeptides
- Receptor-engagement behavior in controlled lab environments
- Evaluation of pathway specificity in multi-peptide systems
For laboratory research only. Educational reference only.
Certificate of Analysis
Certificates of Analysis will be published here as they’re finalized and uploaded. Check back soon for the latest documentation.
General Inquiries
There are no inquiries yet.
Reviews
There are no reviews yet